ArticleBMC ophthalmology2015

Comparison of Eylea® with Lucentis® as first-line therapy in patients with treatment-naïve neovascular age-related macular degeneration in real-life clinical practice: retrospective case-series analysis.

Sophie C Böhni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.